Merkliste 
 1 Ergebnisse 
 
1

Tyrosine kinase inhibitors vandetanib, lenvatinib and caboz..:

Kolarik, Matus ; Indra, Radek ; Adam, Vojtech...
Kolarik , M , Indra , R , Adam , V , Heger , Z , Kopeckova , K , Arlt , V M & Stiborova , M 2019 , ' Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro ' , Neuroendocrinology Letters , vol. 39 , no. 7 , pp. 515-524 ..  , 2019